As research continues, those involved say this would be a game changer, especially for patients with very limited options.

Professor George Obeng Adjei, Director, Centre for Tropical Pharmacology and Therapeutics, University of Ghana Medical School, says clinical trials ...

Tisento Therapeutics has dosed the first subject in its Phase IIb PRIZM study, examining the effects of the oral ...

Gaps remain in biomedical research in frontotemporal dementia; however, there are several means by which these gaps can be bridged.

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

For generations, Native peoples have been pioneers in medicine, carefully testing traditional healing practices to benefit ...

Research at the 2025 STS Annual Meeting indicates anatomical lung resections such as lobectomy are linked to improved survival rates in early-stage NSCLC. Data analysis from over 32,000 patients shows ...

SHELTON, CT / / January 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to ...

One of GPT-4’s key strengths lies in its ability to extract explicit and straightforward information from medical notes. The ...

BRAF V600E-mutant metastatic colorectal cancer (CRC) was associated with poor clinical outcomes in patients receiving ...

The compound was discovered and initially developed by Stony Brook University’s Iwao Ojima, PhD, and Martin Kaczocha, PhD.

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.